About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Omeprazole
- Procedure number
- PSUSA/00002215/202204
- Regulatory outcome
- Variation
Documents
Omeprazole : List of nationally authorised medicinal products - PSUSA/00002215/202204
English (EN) (463.41 KB - PDF)
Omeprazole : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002215/202204
English (EN) (77.38 KB - PDF)
български (BG) (133.63 KB - PDF)
español (ES) (129.46 KB - PDF)
čeština (CS) (159.65 KB - PDF)
dansk (DA) (108.59 KB - PDF)
Deutsch (DE) (136.79 KB - PDF)
eesti keel (ET) (124.7 KB - PDF)
ελληνικά (EL) (156.56 KB - PDF)
français (FR) (128.93 KB - PDF)
hrvatski (HR) (161.76 KB - PDF)
íslenska (IS) (133.18 KB - PDF)
Gaeilge (GA) (116.06 KB - PDF)
italiano (IT) (155.08 KB - PDF)
latviešu valoda (LV) (184.88 KB - PDF)
lietuvių kalba (LT) (212.28 KB - PDF)
magyar (HU) (179.55 KB - PDF)
Malti (MT) (174.29 KB - PDF)
Nederlands (NL) (130.82 KB - PDF)
norsk (NO) (125.62 KB - PDF)
polski (PL) (170.44 KB - PDF)
português (PT) (125.67 KB - PDF)
română (RO) (173.81 KB - PDF)
slovenčina (SK) (177.15 KB - PDF)
slovenščina (SL) (145.64 KB - PDF)
Suomi (FI) (107.03 KB - PDF)
svenska (SV) (39.9 KB - PDF)